Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7EKC

Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2

Summary for 7EKC
Entry DOI10.2210/pdb7ekc/pdb
DescriptorAngiotensin-converting enzyme 2, Spike protein S1, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total)
Functional Keywordssars-cov-2, spike, rbd, 501y.v3, ace2, viral protein, hydrolase-viral protein complex, hydrolase/viral protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight97550.69
Authors
Han, P.C.,Su, C.,Zhang, Y.F.,Qi, J.X.,Gao, G.F. (deposition date: 2021-04-05, release date: 2021-11-03, Last modification date: 2024-11-06)
Primary citationHan, P.,Su, C.,Zhang, Y.,Bai, C.,Zheng, A.,Qiao, C.,Wang, Q.,Niu, S.,Chen, Q.,Zhang, Y.,Li, W.,Liao, H.,Li, J.,Zhang, Z.,Cho, H.,Yang, M.,Rong, X.,Hu, Y.,Huang, N.,Yan, J.,Wang, Q.,Zhao, X.,Gao, G.F.,Qi, J.
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants.
Nat Commun, 12:6103-6103, 2021
Cited by
PubMed Abstract: Multiple SARS-CoV-2 variants of concern (VOCs) have been emerging and some have been linked to an increase in case numbers globally. However, there is yet a lack of understanding of the molecular basis for the interactions between the human ACE2 (hACE2) receptor and these VOCs. Here we examined several VOCs including Alpha, Beta, and Gamma, and demonstrate that five variants receptor-binding domain (RBD) increased binding affinity for hACE2, and four variants pseudoviruses increased entry into susceptible cells. Crystal structures of hACE2-RBD complexes help identify the key residues facilitating changes in hACE2 binding affinity. Additionally, soluble hACE2 protein efficiently prevent most of the variants pseudoviruses. Our findings provide important molecular information and may help the development of novel therapeutic and prophylactic agents targeting these emerging mutants.
PubMed: 34671049
DOI: 10.1038/s41467-021-26401-w
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon